MedGen, Inc. (MDIN) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.89: the stock has moved about 11% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMedGen, Inc. (MDIN) trades at $0.00003. MedGen, Inc. operates an online health and wellness platform, connecting consumers with health information and professionals. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for MDIN: MDIN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
MedGen, Inc. (MDIN) Healthcare & Pipeline Overview
MedGen, Inc., based in Canada, operates an online health and wellness platform, connecting consumers with vital health information and professionals. The company faces competition in the digital health space and operates with a negative P/E ratio, reflecting its current stage of development and market capitalization.
What Is the Investment Thesis for MDIN?
MedGen, Inc. presents a high-risk, high-reward investment profile due to its early stage of development and presence in the competitive online health and wellness market. With a market capitalization of $0.00B and a negative P/E ratio of -600.00, the company's financial metrics indicate it is not yet profitable. The company's beta of 0.89 suggests it is less volatile than the market average. Growth catalysts include successful platform scaling, strategic partnerships with healthcare providers, and expansion into new service offerings. However, potential risks include intense competition, challenges in user acquisition, and the need for significant capital investment to achieve profitability. Investors should carefully consider the company's long-term growth potential and ability to execute its business plan in a rapidly evolving market.
Based on FMP financials and quantitative analysis
MDIN Key Highlights
Reverse merger with 9430075 Canada Ltd. in June 2020, marking a strategic shift towards the online health and wellness platform model.
- Market capitalization of $0.00B indicates the company's small size and early stage of development.
- Negative P/E ratio of -600.00 reflects the company's current lack of profitability.
- Beta of 0.89 suggests the stock is less volatile than the overall market.
- Operates in the growing digital health market, which presents opportunities for expansion and innovation.
Who Are MDIN's Competitors?
MDIN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | 33 5-pillar |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | 39 5-pillar |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | 32 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDIN's Key Strengths?
Online platform provides convenient access to health information and professionals.
- Reverse merger provided a strategic entry into the online health market.
- Potential for network effects as the platform grows.
- Operates in a growing digital health market.
What Are MDIN's Weaknesses?
Small market capitalization and limited financial resources.
- Negative P/E ratio indicates lack of profitability.
- Intense competition in the online health market.
- Reliance on user acquisition and platform adoption.
What Are the Key Risks for MDIN?
Intense competition in the online health market.
- Challenges in user acquisition and platform adoption.
- Need for significant capital investment to achieve profitability.
- Regulatory changes and compliance requirements.
- Data security and privacy concerns.
What Threats Does MDIN Face?
- Regulatory changes and compliance requirements.
- Technological advancements and disruption.
- Data security and privacy concerns.
- Economic downturn and reduced consumer spending.
What Are MDIN's Competitive Advantages?
- Network effects: As more users join the platform, its value increases for both consumers and professionals.
- First-mover advantage: Being an early entrant in the online health and wellness market provides a competitive edge.
- Data assets: Accumulation of user data can be leveraged to personalize the user experience and improve the platform's functionality.
- Brand reputation: Building a trusted brand can attract and retain users.
What Does MDIN Do?
MedGen, Inc. was established in 2015 and significantly evolved through the acquisition of 9430075 Canada Ltd. on June 25, 2020, via a reverse merger. This strategic move positioned MedGen as an operator of an online health and wellness platform. The platform is designed to facilitate connections between consumers seeking health information and referrals and health and wellness professionals aiming to expand their client base. The company is headquartered in Winnipeg, Canada, and focuses on providing a digital space for health-related interactions. MedGen's core offering revolves around its online platform, which serves as a conduit for information dissemination and professional networking within the health and wellness sector. The platform aims to streamline the process by which individuals can access relevant health information and connect with qualified professionals. This approach addresses the growing demand for accessible and convenient healthcare solutions in the digital age. MedGen, Inc. operates within the competitive landscape of online health platforms, facing challenges related to user acquisition, platform development, and market penetration. The company's success hinges on its ability to differentiate its platform, attract both consumers and professionals, and establish a sustainable business model within the evolving digital health market.
What Products and Services Does MDIN Offer?
- Operates an online health and wellness platform.
- Connects consumers with health information and referrals.
- Facilitates connections between consumers and health and wellness professionals.
- Provides a digital space for health-related interactions.
- Aims to streamline access to health information.
- Offers a platform for professional networking within the health and wellness sector.
How Does MDIN Make Money?
- Generates revenue through subscriptions from health and wellness professionals.
- Potential for revenue through advertising and sponsored content.
- Possible future revenue streams from premium services and partnerships.
- Data analytics and insights for healthcare providers (potential).
What Industry Does MDIN Operate In?
MedGen, Inc. operates within the rapidly evolving digital health market. This market is characterized by increasing demand for online health and wellness solutions, driven by factors such as growing internet penetration, rising healthcare costs, and a shift towards preventative care. The competitive landscape includes established players and emerging startups, all vying for market share. MedGen's success depends on its ability to differentiate its platform, attract users, and establish strategic partnerships within the healthcare ecosystem. The industry is subject to regulatory changes and technological advancements, requiring companies to adapt and innovate to remain competitive.
Who Are MDIN's Key Customers?
- Consumers seeking health information and referrals.
- Health and wellness professionals looking to expand their client base.
- Healthcare providers seeking to connect with patients.
- Employers looking to provide wellness benefits to employees (potential).
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
MedGen, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Winnipeg, CA. The company is led by CEO Adir Iakya. MDIN has traded publicly since 2003.
Key Financial Metrics
Return on equity for MedGen, Inc. stands at 36.3%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. Its earnings yield is -0.2%, the inverse of the P/E and a quick read on earnings relative to price.
MDIN Financials
MDIN Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 8, 2019
MDIN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MDIN.
Price Targets
Wall Street price target analysis for MDIN.
MDIN MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MDIN; grades run from A+ (80-100) to F (below 30).
Leadership: Adir Iakya
CEO
Without additional context, it is impossible to provide a detailed biography, including career history, education, and previous roles. Further research would be needed to complete this section.
Track Record: Due to the lack of information on Adir Iakya's background and specific achievements at MedGen, Inc., it is not possible to assess their track record. Key milestones and strategic decisions under their leadership cannot be evaluated without additional data.
MDIN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that MedGen, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited reporting requirements and may not be current in their disclosures. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and regulatory oversight. These companies often have lower trading volumes and greater price volatility compared to those listed on major exchanges.
- OTC Tier: OTC Other
- Limited information and disclosure requirements on the OTC Other tier.
- Low trading volume and liquidity, leading to potential price volatility.
- Potential for lack of regulatory oversight and investor protection.
- Increased risk of fraud or manipulation.
- Difficulty in obtaining accurate and timely financial information.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal standing.
- Determine the company's capital structure and debt levels.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company is incorporated in Canada.
- Company has been in operation since 2015.
- Company operates an online platform, suggesting a modern business model.
- Reverse merger with 9430075 Canada Ltd. indicates a strategic effort to enter the online health market.
Common Questions About MDIN (Healthcare)
What does MedGen, Inc. do?
MedGen, Inc. operates an online health and wellness platform designed to connect consumers with vital health information and health and wellness professionals.
What do analysts say about MDIN stock?
There is no analyst coverage information available for MedGen, Inc. (MDIN) in the provided data. The company's market capitalization is $0.00B, and it has a negative P/E ratio of -600.00, indicating that it is not currently profitable.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on limited data sources.
- OTC market investments carry higher risk.
- Financial metrics may not be up-to-date.